{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:51:05Z","timestamp":1790139065140,"version":"4.0.1"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,23]],"date-time":"2020-01-23T00:00:00Z","timestamp":1579737600000},"content-version":"am","delay-in-days":356,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Raymond Kwok Family Research Fund"},{"name":"Andreas Dracopoulos Research Fund"},{"DOI":"10.13039\/100005800","name":"Eye Bank Association of America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005800","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Richard Lindstrom Research"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01EY027827"],"award-info":[{"award-number":["R01EY027827"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30-EY001765"],"award-info":[{"award-number":["P30-EY001765"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"King Khaled Eye Specialist Hospital of Saudi Arabia"},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81370994"],"award-info":[{"award-number":["81370994"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.jconrel.2019.01.018","type":"journal-article","created":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T01:56:05Z","timestamp":1547690165000},"page":"68-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"special_numbering":"C","title":["Controlled release of corticosteroid with biodegradable nanoparticles for treating experimental autoimmune uveitis"],"prefix":"10.1016","volume":"296","author":[{"given":"Lixia","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumin","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Hartsock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyu","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoo-Chun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuo","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles G.","family":"Eberhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M.","family":"Ensign","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer E.","family":"Thorne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter J.","family":"Stark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elia J.","family":"Duh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3191-0771","authenticated-orcid":false,"given":"Qingguo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Hanes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2019.01.018_bb0005","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF00131163","article-title":"Immunoregulation of uveitis","volume":"14","author":"Nussenblatt","year":"1990","journal-title":"Int. Ophthalmol."},{"key":"10.1016\/j.jconrel.2019.01.018_bb0010","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/00005792-200107000-00005","article-title":"Chronic severe uveitis - etiology and visual outcome in 927 patients from a single center","volume":"80","author":"Bodaghi","year":"2001","journal-title":"Medicine"},{"key":"10.1016\/j.jconrel.2019.01.018_bb0015","first-page":"1891","article-title":"Pharmacotherapy for uveitis: current management and emerging therapy","volume":"8","author":"Barry","year":"2014","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.jconrel.2019.01.018_bb0020","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop","volume":"140","author":"Jabs","year":"2005","journal-title":"Am J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2019.01.018_bb0025","doi-asserted-by":"crossref","first-page":"5561","DOI":"10.1167\/iovs.14-14788","article-title":"Long-term therapeutic effects of mesenchymal stem cells compared to dexamethasone on recurrent experimental autoimmune uveitis of rats","volume":"55","author":"Zhang","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2019.01.018_bb0030","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1167\/iovs.14-15518","article-title":"A new small molecule for treating inflammation and chorioretinal neovascularization in relapsing-remitting and chronic experimental autoimmune uveitis","volume":"56","author":"Diedrichs-Mohring","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2019.01.018_bb0035","first-page":"243","article-title":"Type I interferons as immunoregulatory molecules; implications for therapy in experimental autoimmune uveoretinitis","volume":"50","author":"Mizuguchi","year":"2002","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"10.1016\/j.jconrel.2019.01.018_bb0040","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mce.2010.04.005","article-title":"The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights","volume":"335","author":"Coutinho","year":"2011","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jconrel.2019.01.018_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/nyas.12824","article-title":"Development of a dexamethasone intravitreal implant for the treatment of noninfectious posterior segment uveitis","volume":"1358","author":"Whitcup","year":"2015","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jconrel.2019.01.018_bb0050","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1208\/s12248-010-9183-3","article-title":"Ocular drug delivery","volume":"12","author":"Gaudana","year":"2010","journal-title":"AAPS J."},{"key":"10.1016\/j.jconrel.2019.01.018_bb0055","series-title":"Guidelines for the Use of Immunosuppressive Drugs in Patients with Ocular Inflammatory Disorders: Recommendations of an Expert Panel","first-page":"492","volume":"vol. 130","author":"Jabs","year":"2000"},{"key":"10.1016\/j.jconrel.2019.01.018_bb0060","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1167\/iovs.10-5285","article-title":"Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant","volume":"52","author":"Chang-Lin","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2019.01.018_bb0065","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1586\/ecp.12.55","article-title":"Pharmacologic and clinical profile of dexamethasone intravitreal implant","volume":"5","author":"Robinson","year":"2012","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"10.1016\/j.jconrel.2019.01.018_bb0070","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1001\/archophthalmol.2010.339","article-title":"Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis","volume":"129","author":"Lowder","year":"2011","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.jconrel.2019.01.018_bb0075","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0002-9394(99)00129-4","article-title":"High concentration of dexamethasone in aqueous and vitreous after subconjunctival injection","volume":"128","author":"Weijtens","year":"1999","journal-title":"Am J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2019.01.018_bb0080","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/S0161-6420(00)00344-4","article-title":"Dexamethasone concentration in the subretinal fluid after a subconjunctival injection, a peribulbar injection, or an oral dose","volume":"107","author":"Weijtens","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jconrel.2019.01.018_bb0085","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jconrel.2015.01.009","article-title":"Corticosteroid-loaded biodegradable nanoparticles for prevention of corneal allograft rejection in rats","volume":"201","author":"Pan","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2019.01.018_bb0090","doi-asserted-by":"crossref","first-page":"845","DOI":"10.3109\/02713689409025141","article-title":"Interphotoreceptor retinoid-binding protein derived peptide can induce experimental autoimmune uveoretinitis in various rat strains","volume":"13","author":"Sasamoto","year":"1994","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.jconrel.2019.01.018_bb0095","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1167\/iovs.12-10583","article-title":"The effect of Rho-associated kinase inhibition on the ocular penetration of timolol maleate","volume":"54","author":"Arnold","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2019.01.018_bb0100","unstructured":"Peter J. McDonnell, Yasin A. Khan, Samuel K. Lai, Renata T. Kashiwabuchi, Ashley Behrens, J.S. Hanes, Sustained Delivery of Therapeutic Agents to an Eye Compartment, U.S. Patent No. 8889193 B2, Issued November 18, 2014, in, USA, 2014."},{"key":"10.1016\/j.jconrel.2019.01.018_bb0105","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1084\/jem.20050429","article-title":"Endogenous IRBP can be dispensable for generation of natural CD4+CD25+ regulatory T cells that protect from IRBP-induced retinal autoimmunity","volume":"203","author":"Grajewski","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2019.01.018_bb0110","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1006\/jaut.1993.1048","article-title":"Human S-antigen: presence of multiple immunogenic and immunopathogenic sites in the Lewis rat","volume":"6","author":"de Smet","year":"1993","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jconrel.2019.01.018_bb0115","doi-asserted-by":"crossref","first-page":"4164","DOI":"10.1523\/JNEUROSCI.23-10-04164.2003","article-title":"Increased expression of brain-derived neurotrophic factor preserves retinal function and slows cell death from rhodopsin mutation or oxidative damage","volume":"23","author":"Okoye","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jconrel.2019.01.018_bb0120","doi-asserted-by":"crossref","first-page":"11300","DOI":"10.1073\/pnas.0604056103","article-title":"Antioxidants reduce cone cell death in a model of retinitis pigmentosa","volume":"103","author":"Komeima","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2019.01.018_bb0125","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0896-8411(90)90144-H","article-title":"Pathology of experimental autoimmune uveoretinitis in mice","volume":"3","author":"Chan","year":"1990","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jconrel.2019.01.018_bb0130","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1046\/j.1440-1711.2001.01002.x","article-title":"Real-time reverse transcriptase-polymerase chain reaction (RT-PCR) for measurement of cytokine and growth factor mRNA expression with fluorogenic probes or SYBR Green I","volume":"79","author":"Yin","year":"2001","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.jconrel.2019.01.018_bb0135","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1631\/jzus.B1000030","article-title":"Th17 promotes acute rejection following liver transplantation in rats","volume":"11","author":"Xie","year":"2010","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"10.1016\/j.jconrel.2019.01.018_bb0140","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2172-5-3","article-title":"Rat pro-inflammatory cytokine and cytokine related mRNA quantification by real-time polymerase chain reaction using SYBR green","volume":"5","author":"Peinnequin","year":"2004","journal-title":"BMC Immunol."},{"key":"10.1016\/j.jconrel.2019.01.018_bb0145","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1001\/archopht.1977.04450020112019","article-title":"Periocular injection of corticosteroids-Experimental evaluation of its role in treatment of corneal inflammation","volume":"95","author":"Leibowitz","year":"1977","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.jconrel.2019.01.018_bb0150","first-page":"297","article-title":"An autoradiographic study of the penetration of subconjunctivally injected hydrocortisone into the normal and inflamed rabbit eye","volume":"4","author":"McCartney","year":"1965","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2019.01.018_bb0155","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/bjo.76.11.681","article-title":"Pharmacokinetics of ophthalmic corticosteroids","volume":"76","author":"McGhee","year":"1992","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2019.01.018_bb0160","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1021\/mp2005164","article-title":"Hydrophilic prodrug approach for reduced pigment binding and enhanced transscleral retinal delivery of celecoxib","volume":"9","author":"Malik","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2019.01.018_bb0165","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1124\/dmd.110.037408","article-title":"Influence of drug solubility and lipophilicity on transscleral retinal delivery of six corticosteroids","volume":"39","author":"Thakur","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jconrel.2019.01.018_bb0170","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1021\/js9802594","article-title":"Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye","volume":"87","author":"Prausnitz","year":"1998","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2019.01.018_bb0175","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1002\/anie.201006849","article-title":"Biodegradable nanoparticles composed entirely of safe materials that rapidly penetrate human mucus","volume":"50","author":"Yang","year":"2011","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2019.01.018_bb0180","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/j.ophtha.2014.03.016","article-title":"High-dose subconjunctival cyclosporine A implants do not affect corneal neovascularization after high-risk keratoplasty","volume":"121","author":"Bock","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jconrel.2019.01.018_bb0185","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s13346-014-0196-9","article-title":"Nanomedicine for glaucoma: sustained release latanoprost offers a new therapeutic option with substantial benefits over eyedrops","volume":"4","author":"Wong","year":"2014","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2019.01.018_bb0190","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1021\/acs.molpharmaceut.6b00343","article-title":"Subconjunctival delivery of dorzolamide-loaded poly(ether-anhydride) microparticles produces sustained lowering of intraocular pressure in rabbits","volume":"13","author":"Fu","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2019.01.018_bb0195","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.ophtha.2010.12.014","article-title":"Ophthalmic antibiotics and antimicrobial resistance: a randomized, controlled study of patients undergoing intravitreal injections","volume":"118","author":"Kim","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jconrel.2019.01.018_bb0200","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/2047-783X-17-19","article-title":"Systematic assessment of microneedle injection into the mouse cornea","volume":"17","author":"Matthaei","year":"2012","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.jconrel.2019.01.018_bb0205","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1136\/bjo.2008.154906","article-title":"Penetration of topical and subconjunctival corticosteroids into human aqueous humour and its therapeutic significance","volume":"93","author":"Awan","year":"2009","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2019.01.018_bb0210","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0002-9394(98)00003-8","article-title":"Dexamethasone concentration in vitreous and serum after oral administration","volume":"125","author":"Weijtens","year":"1998","journal-title":"Am J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2019.01.018_bb0215","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1167\/iovs.13-13327","article-title":"Scleral permeability varies by mouse strain and is decreased by chronic experimental glaucoma","volume":"55","author":"Pease","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2019.01.018_bb0220","first-page":"1893","article-title":"Human scleral permeability. Effects of age, cryotherapy, transscleral diode laser, and surgical thinning","volume":"36","author":"Olsen","year":"1995","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2019.01.018_bb0225","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.addr.2006.07.027","article-title":"Challenges and obstacles of ocular pharmacokinetics and drug delivery","volume":"58","author":"Urtti","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2019.01.018_bb0230","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1001\/archopht.1969.00990010790006","article-title":"Increased intraocular pressure following subconjunctival corticosteroid administration","volume":"81","author":"Kalina","year":"1969","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.jconrel.2019.01.018_bb0235","first-page":"155","article-title":"Understanding autoimmunity in the eye: from animal models to novel therapies","volume":"93","author":"Caspi","year":"2014","journal-title":"Disc. Med."},{"key":"10.1016\/j.jconrel.2019.01.018_bb0240","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1292\/jvms.69.1131","article-title":"Age-related changes in ionized calcium-binding adapter molecule 1 immunoreactivity and protein level in the gerbil hippocampal CA1 region","volume":"69","author":"Choi","year":"2007","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.jconrel.2019.01.018_bb0245","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1365-2567.2010.03379.x","article-title":"Retinal cells suppress intraocular inflammation (uveitis) through production of interleukin-27 and interleukin-10","volume":"132","author":"Lee","year":"2011","journal-title":"Immunology"},{"key":"10.1016\/j.jconrel.2019.01.018_bb0250","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.cell.2011.03.050","article-title":"An ADIOL-ERbeta-CtBP transrepression pathway negatively regulates microglia-mediated inflammation","volume":"145","author":"Saijo","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2019.01.018_bb0255","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neuroscience.2012.12.012","article-title":"Corticosteroids limit microglial activation occurring during acute stress","volume":"232","author":"Sugama","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.jconrel.2019.01.018_bb0260","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0165-5728(92)90067-U","article-title":"Chronic inflammatory effects of interleukin-1 on the blood-retina barrier","volume":"41","author":"Martiney","year":"1992","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jconrel.2019.01.018_bb0265","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1136\/bjo.2004.050401","article-title":"The effects of atorvastatin in experimental autoimmune uveitis","volume":"89","author":"Thomas","year":"2005","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2019.01.018_bb0270","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s11064-006-9101-3","article-title":"Ionized calcium-binding adapter molecule 1 immunoreactive cells change in the gerbil hippocampal CA1 region after ischemia\/reperfusion","volume":"31","author":"Hwang","year":"2006","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.jconrel.2019.01.018_bb0275","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/icb.2014.49","article-title":"Distinct spatial distribution of microglia and macrophages following mesenchymal stem cell implantation in mouse brain","volume":"92","author":"Le Blon","year":"2014","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.jconrel.2019.01.018_bb0280","doi-asserted-by":"crossref","first-page":"6891","DOI":"10.1128\/MCB.20.18.6891-6903.2000","article-title":"Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12","volume":"20","author":"Ito","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.jconrel.2019.01.018_bb0285","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1084\/jem.20061864","article-title":"Spontaneous autoimmunity prevented by thymic expression of a single self-antigen","volume":"203","author":"DeVoss","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2019.01.018_bb0290","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jaut.2013.06.003","article-title":"Breakdown of immune privilege and spontaneous autoimmunity in mice expressing a transgenic T cell receptor specific for a retinal autoantigen","volume":"44","author":"Horai","year":"2013","journal-title":"J. Autoimmun."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365919300367?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365919300367?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:37:46Z","timestamp":1759160266000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365919300367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":58,"alternative-id":["S0168365919300367"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2019.01.018","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Controlled release of corticosteroid with biodegradable nanoparticles for treating experimental autoimmune uveitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2019.01.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}